influenza
import
caus
annual
morbid
mortal
prevent
vaccin
also
requir
ongo
surveil
pandem
potenti
result
constant
genet
mutat
influenza
viru
effect
vaccin
depend
continu
monitor
circul
strain
global
influenza
viru
infect
contribut
substanti
annual
burden
respiratori
ill
temper
region
globe
grow
bodi
evid
suggest
also
case
tropic
region
tropic
develop
countri
remain
global
surveil
data
limit
inform
avail
use
inform
influenza
vaccin
treatment
strategi
set
africa
ivoir
virolog
limit
epidemiolog
data
avail
demonstr
pattern
circul
influenza
respiratori
virus
etiolog
respiratori
infect
especi
children
assum
bacteri
origin
result
sentinel
surveil
establish
character
influenza
virus
circul
ivoir
determin
influenza
season
contribut
virus
africa
global
influenza
surveil
network
surveil
year
subset
sentinel
respiratori
specimen
children
age
year
test
addit
respiratori
virus
also
evalu
viral
etiolog
pediatr
ill
studi
use
year
sentinel
surveil
data
describ
circul
season
influenza
ivoir
first
seven
healthcar
center
select
sentinel
surveil
site
locat
citi
abidjan
site
select
use
follow
criteria
geograph
represent
within
abidjan
adequ
throughput
patient
consult
health
facil
exist
depart
gener
medicin
pediatr
depart
laboratori
access
site
avail
desir
physician
particip
voluntarili
without
financi
motiv
surveil
program
avail
refriger
storag
specimen
surveil
system
abidjan
expand
site
twelv
addit
site
ad
five
locat
abidjan
nine
locat
interior
countri
emphasi
eastern
region
focu
local
poultri
husbandri
figur
gener
practition
pediatrician
train
respiratori
specimen
collect
storag
shipment
specimen
laboratori
supervisori
visit
conduct
quarterli
monitor
perform
sentinel
site
includ
valid
total
respiratori
specimen
collect
review
medic
record
determin
actual
number
ili
case
present
sentinel
facil
sentinel
physician
ask
screen
outpati
present
sentinel
site
sign
symptom
ill
accord
cdc
case
definit
temperatur
either
cough
sore
throat
ili
case
surveil
form
includ
clinic
epidemiolog
data
date
ill
onset
date
sampl
collect
patient
name
sex
age
clinic
symptom
vaccin
statu
complet
nasopharyng
np
specimen
collect
ili
case
use
virocult
swab
medic
wire
equip
uk
immedi
store
steril
cryovial
contain
viral
transport
medium
vtm
specimen
kept
follow
collect
transport
respiratori
specimen
transport
three
day
per
week
monday
wednesday
friday
sentinel
site
nation
influenza
center
nic
locat
pasteur
institut
frozen
test
np
specimen
analyz
detect
influenza
virus
period
sentinel
specimen
n
test
use
viral
cultur
year
molecular
detect
convent
revers
transcript
polymeras
chain
reaction
use
sentinel
specimen
n
year
influenza
virus
detect
use
sentinel
specimen
n
follow
introduct
molecular
diagnost
techniqu
viral
cultur
addit
perform
subset
n
case
influenza
virus
avail
antigen
character
year
subset
np
swab
collect
children
age
year
select
detect
rna
respiratori
virus
influenza
virus
b
c
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
parainfluenza
virus
type
human
coronavirus
hcov
rhinoviru
hrv
subset
respiratori
specimen
collect
within
day
first
symptom
onset
simpl
random
sampl
perform
select
specimen
multipathogen
test
select
mani
specimen
avail
reagent
would
allow
us
test
respiratori
specimen
collect
patient
age
year
receiv
laboratori
within
day
np
swab
collect
select
multipathogen
test
respiratori
specimen
collect
year
specimen
select
viru
isol
inocul
madin
darbi
canin
kidney
mdck
cell
medium
contain
trypsin
cultur
maintain
least
day
steam
room
influenza
virus
detect
cultur
use
elisa
immunocaptur
method
accord
protocol
institut
pasteur
pari
hemmaglutin
test
red
blood
cell
chicken
perform
cultur
supernat
hour
incub
case
posit
result
hai
undertaken
use
specif
antisera
influenza
pandem
influenza
influenza
b
virus
refer
strain
specif
antisera
suppli
refer
center
lyon
franc
collabor
center
cdc
atlanta
usa
cell
cultur
perform
posit
sampl
rna
extract
specimen
perform
use
qiamp
viru
rna
mini
kit
qiagen
qiagen
sa
avenu
du
canada
courtaboeuf
cedex
franc
rna
elut
final
volum
store
perform
day
longer
storag
carri
earli
convent
assay
perform
final
volum
rna
primer
u
rnase
inhibitor
promega
parc
de
charbonnier
franc
enzym
mix
superscript
ii
onestep
system
invitrogen
life
scienc
research
product
accesorio
para
laboratorio
sa
de
cv
col
anzur
mexico
hemagglutinin
ha
gene
season
virus
amplifi
specif
primer
use
protocol
develop
institut
pasteur
du
cambodg
primer
protocol
avail
upon
request
detect
respiratori
virus
three
multiplex
assay
carri
describ
et
al
target
follow
rna
respiratori
virus
simultan
influenza
virus
b
c
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
parainfluenza
virus
type
human
coronavirus
hcov
rhinoviru
hrv
amplifi
product
visual
electrophoresi
ethidium
agaros
gel
follow
purchas
abi
machin
appli
biosystem
foster
citi
ca
usa
perform
assay
use
panel
oligonucleotid
primer
hydrolysi
probe
accord
cdc
protocol
detect
character
influenza
b
swine
influenza
viru
rna
use
method
develop
nic
nord
de
franc
assay
target
gene
detect
influenza
viru
ha
gene
specif
detect
pandem
influenza
season
influenza
influenza
virus
primer
probe
design
avail
upon
request
gripp
pasteurfr
test
perform
final
volum
abi
appli
biosystem
platform
use
superscript
iii
platinum
quantit
system
invitrogen
optim
primer
probe
enzym
mix
rna
thermocycl
reaction
condit
describ
duchamp
bm
et
al
revers
transcript
incub
time
min
neg
control
includ
run
season
specimen
sent
either
institut
pasteur
pari
collabor
center
atlanta
andor
london
advanc
analysi
antivir
resist
test
genet
sequenc
surveil
data
analyz
evalu
tempor
trend
number
ili
case
percent
case
test
posit
influenza
sentinel
site
influenza
surveil
specimen
consist
collect
submit
throughout
year
overlay
epidemiolog
virolog
data
meteorolog
data
monthli
rainfal
rel
humid
averag
daili
temperatur
data
obtain
airport
author
ivoir
make
descript
assess
relationship
percent
sentinel
specimen
test
posit
influenza
meteorolog
variabl
epidemiolog
virolog
data
also
analyz
age
year
month
sentinel
site
age
categor
base
age
group
year
statist
test
compar
percentag
sentinel
specimen
test
posit
viral
cultur
versu
molecular
diagnost
techniqu
comparison
distribut
viral
respiratori
pathogen
age
group
undertaken
use
test
analys
perform
softwar
epi
info
epi
info
version
epi
center
diseas
control
prevent
atlanta
ga
usa
analysi
routin
collect
public
health
surveil
data
studi
requir
approv
institut
review
board
total
respiratori
specimen
collect
sentinel
health
center
five
sentinel
site
includ
four
abidjan
one
interior
countri
collect
specimen
specimen
collect
tabl
figur
sentinel
ili
site
six
also
site
offici
serv
person
year
age
contribut
sentinel
specimen
age
popul
enrol
sentinel
surveil
system
rang
month
year
age
group
repres
ili
case
known
age
sex
ratio
malefemal
specimen
date
onset
symptom
record
respiratori
specimen
collect
within
four
day
symptom
onset
ili
specimen
valid
data
date
specimen
collect
sentinel
specimen
receiv
nic
within
three
fewer
day
specimen
collect
ili
case
report
known
influenza
vaccin
statu
report
influenza
vaccin
year
prior
onset
symptom
year
surveil
specimen
test
test
posit
influenza
virus
posit
specimen
initi
confirm
use
viru
isol
techniqu
convent
specimen
confirm
molecular
diagnost
techniqu
viral
cultur
attempt
specimen
produc
viral
isol
percentag
sentinel
specimen
test
posit
influenza
specimen
initi
confirm
use
viral
cultur
specimen
initi
confirm
use
molecular
diagnost
techniqu
p
sentinel
ili
case
comprehens
detect
test
everi
month
observ
peak
percent
sentinel
specimen
test
posit
influenza
may
june
octob
primari
peak
may
june
appear
correl
raini
season
figur
among
sentinel
ili
specimen
test
peak
month
influenza
activ
may
june
octob
specimen
test
posit
influenza
virus
percentag
sentinel
specimen
test
posit
influenza
similar
rang
ili
specimen
valid
data
age
patient
respiratori
specimen
test
posit
influenza
among
among
among
among
among
person
age
year
older
person
confirm
influenza
viru
infect
person
influenza
viru
infect
influenza
b
viru
infect
nine
person
influenza
b
virus
subtyp
influenza
virus
subtyp
season
influenza
influenza
pandem
virus
tabl
year
surveil
season
influenza
viru
domin
influenza
viru
detect
year
influenza
viru
year
influenza
b
virus
influenza
virus
year
first
case
pandem
influenza
viru
infect
detect
june
influenza
viru
repres
influenza
virus
detect
season
influenza
virus
detect
tabl
figur
year
surveil
strain
antigen
character
gener
good
match
virus
includ
northern
hemispher
vaccin
year
tabl
addit
test
influenza
virus
screen
respiratori
virus
carri
respiratori
specimen
collect
children
age
year
sent
within
day
first
symptom
onset
laboratori
median
age
case
year
rang
month
year
children
test
posit
one
respiratori
virus
children
test
posit
influenza
virus
hrsv
common
respiratori
viru
detect
sampl
follow
hrv
influenza
virus
parainfluenza
virus
coronaviru
coronaviru
hmpv
among
children
test
posit
respiratori
viru
greater
percentag
infant
age
year
test
posit
hrsv
children
age
year
howev
children
age
year
test
posit
respiratori
viru
significantli
like
infant
test
posit
influenza
coronaviru
infect
tabl
sentinel
surveil
influenza
virus
expand
substanti
ivoir
recent
year
contribut
data
season
influenza
influenza
virus
circul
contribut
ili
outpati
tropic
region
africa
np
specimen
collect
sentinel
patient
ili
test
posit
influenza
among
sentinel
ili
specimen
test
peak
month
influenza
activ
may
june
octob
test
posit
influenza
virus
percentag
similar
may
observ
winter
season
northern
hemispher
temper
climat
percent
sentinel
specimen
test
p
may
observ
winter
season
northern
hemispher
temper
climat
system
also
highlight
contribut
influenza
virus
rel
respiratori
virus
children
fever
respiratori
symptom
inde
identifi
viral
respiratori
pathogen
associ
ili
case
among
sampl
children
age
year
influenza
virus
circul
throughout
year
ivoir
peak
observ
month
mayjun
octob
month
may
june
correspond
primari
raini
season
octob
occur
secondari
raini
season
although
descript
find
suggest
associ
influenza
activ
rainfal
appear
consist
studi
carri
dosseh
et
al
seneg
howev
less
clear
factor
may
associ
secondari
peak
influenza
activ
observ
although
period
lower
temperatur
rel
humid
ivoir
importantli
antigen
character
limit
subset
influenza
strain
circul
ivoir
gener
suggest
good
match
includ
northern
hemispher
influenza
vaccin
composit
although
carri
specif
antigen
analys
strain
match
howev
time
frame
person
ili
report
receiv
influenza
vaccin
past
year
ivoir
season
influenza
vaccin
current
recommend
parent
young
children
also
pilgrim
mecca
addit
market
formul
northern
hemispher
vaccin
produc
current
level
vaccin
uptak
low
appar
high
degre
match
recent
season
circul
virus
includ
northern
hemispher
vaccin
would
seem
suggest
current
licens
vaccin
suitabl
use
ivoir
children
age
year
age
compris
sentinel
ili
case
owe
particip
rel
larger
number
pediatrician
sentinel
surveil
system
howev
proport
ili
specimen
test
posit
influenza
virus
similar
across
age
group
suggest
circul
influenza
virus
throughout
gener
popul
addit
work
highlight
burden
influenza
among
person
sever
ill
age
eg
hospit
ill
impact
influenza
person
underli
chronic
condit
need
highlight
subpopul
might
priorit
vaccin
antivir
treatment
reason
ivoir
expand
sentinel
system
includ
hospit
patient
sever
acut
respiratori
infect
sari
time
system
combin
exist
ili
surveil
help
identifi
person
risk
complic
influenza
howev
surveil
data
provid
initi
support
potenti
public
health
benefit
influenza
vaccin
programm
ivoir
analys
also
subject
sever
limit
sentinel
site
involv
surveil
one
sentinel
site
cliniqu
du
grand
centr
yopougon
abl
provid
specimen
throughout
surveil
period
four
sentinel
site
provid
respiratori
specimen
highlight
challeng
establish
sentinel
site
surveil
demonstr
feasibl
sentinel
site
particip
surveil
system
term
administr
clinic
staff
commit
polit
willing
logist
data
collect
specimen
transfer
critic
consid
select
sentinel
site
also
therefor
possibl
specif
popul
pocket
influenza
activ
may
captur
sentinel
earli
year
surveil
prior
implement
molecular
diagnost
techniqu
ivoir
nine
percent
sampl
collect
period
sentinel
surveil
influenza
involv
gener
microbi
surveil
activ
institut
pasteur
ivoir
limit
abidjan
citi
although
surveil
permit
us
collect
first
data
circul
influenza
virus
ivoir
period
limit
motiv
among
medic
doctor
sustain
activ
could
explain
increas
workload
percept
influenza
benign
mild
diseas
seen
time
prioriti
term
public
health
reason
assess
influenza
season
limit
year
data
consist
report
multipl
sentinel
site
critic
line
work
african
region
identifi
better
way
provid
incent
clinician
particip
sentinel
surveil
regard
develop
sensit
rapid
diagnost
test
may
use
clinic
hospit
set
could
better
allow
surveil
inform
clinic
manag
increas
relev
particip
clinician
follow
occurr
outbreak
highli
pathogen
avian
influenza
among
poultri
ivoir
clinician
percept
influenza
began
chang
nation
pandem
influenza
prepared
plan
develop
support
center
diseas
control
prevent
cooper
agreement
ministri
health
ivoir
plan
call
reinforc
influenza
surveil
capac
countri
strengthen
influenza
diagnost
techniqu
within
institut
pasteur
ivoir
consequ
annual
averag
number
respiratori
specimen
collect
time
higher
period
demonstr
ancillari
benefit
pandem
prepared
activ
strengthen
routin
surveil
infrastructur
turn
avail
monitor
circul
futur
epidem
pandem
ad
valu
surveil
system
demonstr
rel
contribut
influenza
respiratori
virus
ill
studi
confirm
presenc
respiratori
virus
addit
influenza
virus
import
contributor
outpati
ili
morbid
also
demonstr
studi
africa
larg
major
ili
case
children
age
associ
respiratori
viru
infect
rsv
rhinovirus
influenza
virus
parainfluenza
virus
contribut
medic
attend
ili
find
influenza
also
import
rel
contributor
ili
across
age
also
support
notion
avail
time
use
neuraminidas
inhibitor
could
help
reduc
burden
febril
respiratori
diseas
set
particularli
recent
year
data
collect
use
standard
case
definit
sever
sentinel
facil
made
possibl
interpret
trend
influenza
activ
time
interpret
pattern
season
diseas
intens
introduct
first
case
influenza
associ
influenza
ivoir
increas
awar
mobil
resourc
surveil
period
strengthen
capac
nation
monitor
system
howev
question
sustain
aris
today
context
econom
auster
scarciti
fund
possibl
limit
ili
surveil
repres
subset
effici
function
sentinel
site
continu
establish
sentinel
surveil
sari
hospit
allow
surveil
system
effect
monitor
influenza
viru
circul
season
addit
provid
data
person
risk
sever
complic
influenza
taken
togeth
data
may
also
abl
provid
comprehens
understand
burden
influenza
ivoir
effect
inform
futur
influenza
vaccin
antivir
treatment
polici
